Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Efficacy and Safety of Oral/iv Therapy (Cangrelor) in Patients With SCAD Undergoing Complex PCI, the RESPONSE Study"

NCT04251039 is registered in ClinicalTrials.gov with Fondazione GISE Onlus as lead sponsor.

NCT NCT04251039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04251039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Efficacy and Safety of Oral/iv Therapy (Cangrelor) in Patients With SCAD Undergoing Complex PCI, the RESPONSE Study"
Lead sponsor
Fondazione GISE Onlus
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2022
Completion date
December 31, 2023
Enrollment
550 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary disease